Showing results (1901-1910 of 1,957) with videos related to
Sort By:
Pageof 196
Endoscopy|April 12, 2017
Adenoma detection with blue-water infusion colonoscopy: a randomized trialAdriane Lesne, Olivier Rouquette, Sandrine Touzet, et al.Cell Reports|August 1, 2023
Genome-wide association studies of human and rat BMI converge on synapse, epigenome, and hormone signaling networksSarah N Wright, Brittany S Leger, Sara Brin Rosenthal, et al.The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.The New Phytologist|June 19, 2026
Eco-evolutionary context modifies a destructive plant invader's response to climateMegan L Vahsen, Justin J Van Ee, Diana Gamba, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2023
Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementiaGianina Toller, Yann Cobigo, Patrick Callahan, et al.Sleep & Breathing = Schlaf & Atmung|December 24, 2018
Sex differences in mandibular repositioning device therapy effectiveness in patients with obstructive sleep apnea syndromeMarie-Françoise Vecchierini, Valérie Attali, Jean-Marc Collet, et al.Plos Biology|November 25, 2024
Reconstructing the last common ancestor of all eukaryotesThomas A Richards, Laura Eme, John M Archibald, et al.Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomesSylvanus Toikumo, Mariela V Jennings, Benjamin K Pham, et al.Nature Human Behaviour|April 17, 2024
Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomesSylvanus Toikumo, Mariela V Jennings, Benjamin K Pham, et al.Journal of Medicinal Chemistry|September 20, 2022
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, et al.Pageof 196